Prevalence of Renal Neoplasia in Autosomal Dominant Polycystic Kidney Disease: Systematic Review and Meta-Analysis
Nephron · 2024 · 148 (7) · 457-467
DOI: 10.1159/000536245 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nephron, online erschienen am 01.02.2024. Verfasst von Anna M Drake und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Rural Health, Monash University, Bendigo, Victoria, Australia. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Dominant, Kidney Neoplasms, Carcinoma, Renal Cell. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited condition; however, its relationship with renal cell carcinoma (RCC) remains unclear. This paper aims to establish the prevalence of RCC and its subtypes amongst ADPKD patients.
Methods
A database search was conducted to retrieve studies reporting RCC occurrence within ADPKD patients until July 2023. Key outcomes included number and subtype of RCC cases, and number of RCCs presenting incidentally. A random-effects meta-analysis was performed.
Results
Our search yielded 569 articles, 16 met the inclusion criteria. Nephrectomy specimens from 1,147 ADPKD patients were identified. Of studies reporting per-kidney results (n = 13), 73 RCCs were detected amongst 1,493 kidneys, equating to a per-kidney prevalence of 4.3% (95% CI, 3.1–5.7, I2 = 15.7%). 75 ADPKD patients were found to have RCC (75/1,147), resulting in a per-person prevalence of 5.7% (95% CI, 3.7–7.9, I2 = 40.3%) (n = 16). As 7 patients had bilateral disease, 82 RCCs were detected in total. Of these, 39 were clear cell RCC, 35 were papillary and 8 were other. As such, papillary RCCs made up 41.1% (95% CI, 25.9–56.9, I2 = 18.1%) of detected cancers. The majority of RCCs were detected incidentally (72.5% [95% CI, 43.7–95.1, I2 = 66.9%]).
Conclusion
ADPKD appears to be associated with the papillary RCC subtype. The clinical implications of these findings are unclear, however, may become apparent as outcomes and life expectancy amongst APDKD patients improve.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Rural Health, Monash University, Bendigo, Victoria, Australia.
- Department of Urology, Bendigo Health, Bendigo, Victoria, Australia.
- Department of Urology, Austin Health, Melbourne, Victoria, Australia.
- Department of Paediatrics, Monash University, Melbourne, Victoria, Australia.
Zitieren
APA
Drake, A. M., Paynter, J. A., Yim, A., Tempo, J. A., Manning, T. G., Brennan, J., & Qin, K. R. (2024). Prevalence of Renal Neoplasia in Autosomal Dominant Polycystic Kidney Disease: Systematic Review and Meta-Analysis. Nephron, 148(7), 457-467. https://doi.org/10.1159/000536245
Vancouver
Drake AM, Paynter JA, Yim A, Tempo JA, Manning TG, Brennan J, et al. Prevalence of Renal Neoplasia in Autosomal Dominant Polycystic Kidney Disease: Systematic Review and Meta-Analysis. Nephron. 2024;148(7):457-467. doi:10.1159/000536245
BibTeX
@article{Drake2024,
author = {Drake, Anna M and Paynter, Jessica A and Yim, Arthur and Tempo, Jake A and Manning, Todd G and Brennan, Janelle and Qin, Kirby R},
title = {Prevalence of Renal Neoplasia in Autosomal Dominant Polycystic Kidney Disease: Systematic Review and Meta-Analysis},
journal = {Nephron},
year = {2024},
volume = {148},
number = {7},
pages = {457--467},
doi = {10.1159/000536245}
}
EUVIMED